Kevin Jasas

Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study

Luis Paz‐Ares, Óscar Juan, Giannis Mountzios et al. · Journal of Clinical Oncology · 2024 · 115 citations · Full text

Medicine, Oncology, Pharmacology +17

A Multicenter Open-Label Study to Assess the Safety of a New Formulation of BLP25 Liposome Vaccine in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer

Charles Butts, R. Nevin Murray, Colum J Smith et al. · Clinical Lung Cancer · 2010 · 64 citations

Pharmacy, Immunology, Oncology +16

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial

Andrew R. Davidson, A.-S. Veillard, Annette Tognela et al. · Annals of Oncology · 2015 · 33 citations

Medicine, Oncology, Pharmacology +13

Exercise as Medicine in the Management of Pancreatic Cancer

Prue Cormie, Nigel Spry, Kevin Jasas et al. · Medicine & Science in Sports & Exercise · 2013 · 29 citations

Medicine, Oncology, Rehabilitation Medicine +17

Phase II study of erlotinib (OSI 774) in women with recurrent or metastatic endometrial cancer: NCIC CTG IND-148

Kevin Jasas, Anthony Fyles, L. Elit et al. · Journal of Clinical Oncology · 2004 · 20 citations

Medicine, Oncology, Pharmacology +17